leisure time -WSS

leisure time

author：leisure time 2025-09-04 02:31:49 - browse：225

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： EQRx, failed developer of low

WSS

Mitch McConnell episode has important public health takeaway

Experimental asthma app from Apple and Anthem shows promise

Pence says 'crackpot lawyers' told Trump what he wanted to hear

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Medicare’s new pay boost for primary care is angering specialists

Wikipedia

leisure time

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Medicare proposal to cover medical devices draws a mixed reaction

Infectious disease expert Jeanne Marrazzo assumes Fauci role

In Memoriam: Notable people who died in 2023

Trump indictment: Who are the 'co

Dobbs anniversary: the lost opportunity of abortion as health care

Mega Millions pot grows to $1.25 billion after no winner

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mitch McConnell episode has important public health takeaway

entertainment

Mitch McConnell episode has important public health takeaway

Vertex non

NIH launches clinical trials and new research office for long Covid

NIH launches clinical trials and new research office for long Covid

Trump indictment: Who are the 'co

New safety details link Apellis eye drug to rare cases of blindness

Wikipedia

focus

Wikipedia

leisure time